-
Symbol
-
TSHA on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.00001 per share
-
Latest Disclosed Shares Owned
-
27,662,481 shares
-
Security Ownership %
-
9.9%
Shares, Excluding Options vs Price
RA Capital Management, L.P. ownership in Taysha Gene Therapies, Inc. Common Stock, par value $0.00001 per share (TSHA)
14 Nov 2025 - RA Capital Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 27,662,481 shares of Taysha Gene Therapies, Inc. Common Stock, par value $0.00001 per share (TSHA).
This represents 9.9% ownership of the company.
In their previous filing dated 14 Aug 2025, RA CAPITAL MANAGEMENT, L.P. had reported owning 25,345,988 shares, indicating an increase of +9.1%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.